Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | CXCR1 | P25024 | 5/20 | 0.69 |
| ▸ | CXCR2 | P25025 | 5/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.66 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.66 |
| ▸ | ALB | P02768 | 1/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | RARB | P10826 | 1/20 | 0.66 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.66 |
| ▸ | HTR2A | P28223 | 1/20 | 0.66 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.66 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.66 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ibuproxam SCHEMBL10428212 | 1.00 | CHRM1 (1.00) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| Ibuproxam SCHEMBL8722617 | 1.00 | CHRM1 (1.00) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| Ibuproxam SCHEMBL28086418 | 0.94 | CHRM1 (0.88) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL6740240 | 0.89 | CHRM1 (0.79) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL6740243 | 0.89 | CHRM1 (0.79) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL19953817 | 0.86 | CHRM1 (0.75) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL3147555 | 0.86 | CHRM1 (0.75) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL3142734 | 0.86 | CHRM1 (0.75) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL31006096 | 0.86 | CHRM1 (0.75) | CHRM1PDE4ACXCR1CXCR2PTGS1 | |
| SCHEMBL23763764 | 0.84 | CHRM1 (0.73) | CHRM1PDE4ACXCR1CXCR2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4566 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177565-A1 | METHODS AND MATERIALS FOR INHIBITING/PREVENTING THE TRAFFICKING OF MONOCYTES TO THE CENTRAL NERVOUS SYSTEM | DARTMOUTH COLLEGE (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250041208-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2025-02-06 | — | — | US | claimed |
| EP-3508501-B1 | USE OF ANTI-CGRP ANTIBODIES AND ANTIBODY FRAGMENTS TO PREVENT OR INHIBIT PHOTOPHOBIA OR LIGHT AVERSION IN SUBJECTS IN NEED THEREOF, ESPECIALLY MIGRAINE SUFFERERS | H LUNDBECK AS (DK) | 2024-11-06 | — | — | EP | claimed |
| EP-4444277-A1 | NEW INJECTABLE COMBINATION FORMULATION | Nanexa AB (SE) | 2024-10-16 | — | — | EP | claimed |
| EP-4340884-A1 | TREATMENT OF INFECTIONS IN AND AROUND THE EYE | University of Miami (US) | 2024-03-27 | — | — | EP | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| WO-2023173054-A1 | METHODS AND MATERIALS FOR INHIBITING/PREVENTING THE TRAFFICKING OF MONOCYTES TO THE CENTRAL NERVOUS SYSTEM | THE TRUSTEES OF DARTMOUTH COLLEGE (US) | 2023-09-14 | — | — | WO | claimed |
| WO-2023105227-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2023-06-15 | — | — | WO | claimed |
| WO-2022245950-A1 | TREATMENT OF INFECTIONS IN AND AROUND THE EYE | UNIVERSITY OF MIAMI (US) | 2022-11-24 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995007076-A1 | INCLUSION COMPLEXES OF RACEMIC IBUPROXAM AND OF OPTICALLY ACTIVE IBUPROXAM WITH CYCLODEXTRIN DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THESE INCLUSION COMPLEXES OR CONTAINING OPTICALLY ACTIVE S-(+)-IBUPROXAM, AND USE THEREOF | LEK, TOVARNA FARMACEVTSKIH IN KEMIC^¿NIH IZDELKOV, D.D., LJUBLJANA (SI) | 1995-03-16 | — | — | WO | claimed |
| EP-0268215-B1 | INCLUSION COMPLEX OF IBUPROXAM WITH BETA-CYCLODEXTRIN, A PROCESS FOR PREPARING THE SAME AND A PHARMACEUTICAL PREPARATION CONTAINING THE SAME | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) | 1993-10-06 | — | — | EP | claimed |
| EP-0551626-A1 | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) | 1993-07-21 | — | — | EP | claimed |
| US-4952565-A | WATER SOLUBLE; ANAGESICS, ANTIPYRETICS, ANTIINFLAMMATORY | LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, A CORP. OF YUGOSLAVIA (MK) | 1990-08-28 | — | — | US | claimed |
| WO-1990001929-A1 | NEW MEDICAL USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-03-08 | — | — | WO | claimed |
| EP-0268215-A1 | Inclusion complex of ibuproxam with beta-cyclodextrin, a process for preparing the same and a pharmaceutical preparation containing the same | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) | 1988-05-25 | — | — | EP | claimed |
| US-4061668-A | Process for the preparation of 2-(4-isobutylphenyl)-propiohydroxamic acid | SOCIETA ITALO-BRITANNICA L. MANETTI - H. ROBERTS & C. (IT) | 1977-12-06 | — | — | US | claimed |